Literature DB >> 16874160

The third component of the complement (C3) is a marker of the risk of atherogenesis.

Vincenzo Capuano1, Teodora D'Arminio, Giuseppe La Sala, Gianfranco Mazzotta.   

Abstract

AIM: The aim of this study was to assess the association between the third component of the complement (C3) and other risk factors of coronary heart disease. METHODS AND
RESULTS: We evaluated 1200 individuals aged 25-74 years (600 men and 600 women). A strong relationship was shown between serum C3 and both body mass index (BMI, P<0.01) and fibrinogen (P<0.01). We found a significant, independent correlation with: platelet count (P<0.01), insulin level (P<0.01), triglycerides (P<0.01), low-density lipoprotein (LDL) cholesterol (P<0.01), and an inverse correlation with cigarette smoking (P<0.01).
CONCLUSIONS: A high concentration of C3 is a marker of a profile at risk of atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16874160     DOI: 10.1097/01.hjr.0000224485.80349.76

Source DB:  PubMed          Journal:  Eur J Cardiovasc Prev Rehabil        ISSN: 1741-8267


  6 in total

Review 1.  Biomarkers of obesity and subsequent cardiovascular events.

Authors:  Salma Musaad; Erin N Haynes
Journal:  Epidemiol Rev       Date:  2007-05-10       Impact factor: 6.222

2.  Trend in prevalence of uncontrolled total serum cholesterol for cardio-cerebro-vascular disease in a mediterranean area, 1988/89-2008/09.

Authors:  Vincenzo Capuano; Norman Lamaida; Ernesto Capuano; Maria Immacolata Borrelli; Rocco Capuano; Elisabetta Notari; Anna Grazia Iannone; Federica Marchese; Matteo Sonderegger; Eduardo Capuano
Journal:  World J Cardiol       Date:  2013-11-26

3.  Levels of acylation stimulating protein and the complement component 3 precursor are associated with the occurrence and development of coronary heart disease.

Authors:  Honglei Jiang; Miao Guo; Linping Dong; Chunlin Cao; Dong Wang; Xiaotang Liang; Fang Guo; Zhaoqin Xing; Peili Bu; Jidong Liu
Journal:  Exp Ther Med       Date:  2014-10-13       Impact factor: 2.447

4.  Global screening of human cord blood proteomes for biomarkers of toxic exposure and effect.

Authors:  David R Colquhoun; Lynn R Goldman; Robert N Cole; Marjan Gucek; Malini Mansharamani; Frank R Witter; Benjamin J Apelberg; Rolf U Halden
Journal:  Environ Health Perspect       Date:  2008-12-02       Impact factor: 9.031

5.  Anticomplement therapy.

Authors:  Prathit A Kulkarni; Vahid Afshar-Kharghan
Journal:  Biologics       Date:  2008-12

6.  Trends of Prevalence of Uncontrolled Risk Factors for Cerebrocardiovascular Disease: Southern Italy from 1988/9 to 2008/9.

Authors:  Vincenzo Capuano; Norman Lamaida; Ernesto Capuano; Rocco Capuano; Eduardo Capuano; Gianfranco Mazzotta
Journal:  Cholesterol       Date:  2016-04-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.